Allergan is considering a bid to buy rival drugmaker Shire, competing against Takeda, whose earlier $60 billion offer was rejectedhttps://on.wsj.com/2JYZVIZ
4 replies
17 retweets
20 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.